Ebola vaccine gets $115M to speed development
Johnson & Johnson said on Friday that newly formed groups supporting work on its experimental Ebola vaccine would receive 100 million euros ($115 million) from Europe’s Innovative Medicines Initiative to speed development. The U.S. drug maker earlier this month announced it had started clinical trials of its two-injection vaccine, which uses a booster from Denmark’sBavarian Nordic, making it the third such product to enter human...